Willer, T., Inamori, K., Venzke, D., Harvey, C.D., Morgensen, G., Hara, Y., Beltrán Valero de Bernabé, D., Yu, L., Wright, K.M., Campbell, K.P. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation. eLife 3;3:e03941, 2014. [PDF]

Inamori, K., Willer, T., Hara, Y., Venzke, D., Anderson, M.E., Clarke, N.F., Guicheney, P., Bönnemann, C.G., Moore, S.A., Campbell, K.P. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues. J Biol Chem 280(41): 28138-48, 2014. [PDF]

Lin, S.-S., Tzeng, B.-H., Lee, K.-R., Smith, R.J., Campbell, K.P. and Chen, C.-C. Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage. Proc Natl Acad Sci  111: E1990-E1998, 2014. [PDF]

Wallace, SE, Conta, JH, Winder, TL, Willer, T, Eskuri, JM, Haas, R, Patterson, K, Campbell, KP, Moore, SA, Gospe, SM. A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. Neuromuscul Disord 24: 312-320, 2014. [PDF]

Nguyen, H., Ostendorf, A.P., Satz, J.S., Westra, S., Ross-Barta, S.E., Campbell, K.P., Moore, S.A. Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins. Acta Neuropahol Commun 1 (1): 58, 2013. [PDF]

Goddeeris, M.M., Wu, B., Venzke, D., Yoshida-Moriguchi, T., Saito, F., Matsumura, K., Moore, S.A., Campbell, K.P. Large glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature 503: 136-40, 2013. [PDF]

Yoshida-Moriguchi, T., Willer, T., Anderson, ME, Venzke, D., Whyte, T., Muntoni, F., Lee, H., Nelson, SF, Yu, L., Campbell, KP. SGK196 is a Glycosylation-Specific O-Mannose Kinase Required for Dystroglycan Function. Science 341: 896-9, 2013. [PDF]

Yang, AC, Ng, BG, Moore, SA, Rush, J, Waechter, CJ, Raymond, KM, Willer, T, Campbell, KP, Freeze, HH, Mehta, L. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy. Mol Genet Metab 110(3): 345-351, 2013. [PDF]

Carss, KJ, Stevens, E, Foley, AR, Cirak, S, Riemersma, M, Torelli, S, Hoischen, A, Willer, T, von Scherpenzeel, M, Moore, SA, Messina, S, Bertini, E, Bonnemann, C, Abdenur, JE, Grosmann, AK, Punetha, J, Quinlivan, R, Waddell, LB, Young, HK, Wraige, E, Yau, S, Brodd, L, Feng, L, Sewry, C, MacArthur, DG, North, KN, Hoffman, E, Stemple, DL, Hurles, ME, van Bokhoven, H, Campbell, KP, Lefeber, DJ, UK10K consortium, Lin, YY, Muntoni, F. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Am J Hum Genet  93: 1-13, 2013. [PDF]

Levy, J.R. and Campbell, K.P. Illuminating regeneration: noninvasive imaging of disease progression in muscular dystrophy. J Clin Invest. 123: 1931-4, 2013. [PDF] 

Stevens, E., Carss, K., Cirak, S., Foley, A.R., Torelli, S., Willer, T., Manzini, C., UK10K consortium, Yau, M., Brodd, L., Sewry, C., Topaloglu, H., Haliloglu, G., Walsh, C., Hurles, M., Campbell, K.P., Stemple, D., Lin, Y. and Muntoni, F. Mutations in B3GalNT2 cause a novel congenital muscular dystrophy and hypoglycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 92: 354-65, 2013. [PDF]

Cirak, S., Foley, A.R., Herrmann, R., Willer, T., Stevens, E., Yau, S., Brodd, L., Torelli, S., Kamynina, A., Vondracek, P., Roper, H., Longman, C., Korinthenberg, R., Marrosu, G., Nürnberg, P., UK10K Consortium, Plagnol, V., Hurles, M., Sewry, C., Campbell, K.P., Voit, T. and Muntoni, F. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain 136 (1): 269-81, 2013. [PDF]

Esser AK, Miller MR, Huang Q, Meier MM, Beltran-Valero de Bernabe D, Stipp CS, Campbell KP, Lynch CF, Smith BJ, Cohen MB, Henry MD. Loss of LARGE2 Disrupts Functional Glycosylation of α-Dystroglycan in Prostate Cancer. J Biol Chem 288: 2132-42, 2013[PDF]

Myshrall, T.D, Moore, S.A., Ostendorf, A.P., Satz, J.S., Kowalczyk, T., Nguyen, H., Daza, R.A.M., Lau, C., Campbell, K.P., Hevner, R.F. Dystroglycan on Radial Glia End feet is Required for Pial Basement Membrane Integrity and Columnar Organization of the Developing Cerebral Cortex. J Neuropath Exp Neurol. 71(12): 1047-63, 2012. [PDF]

Inamori K.I., Hara Y., Willer T., Anderson M.E., Zhu Z., Yoshida-Moriguchi T., Campbell K.P. Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2. Glycobiology 23: 295-302, 2013. [PDF]

Moraz, M.L., Pythoud, C., Turk, R., Rothenberger, S., Pasquato, A., Campbell, K.P., Kunz, S. Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan. Cell Microbiol 15(5): 689-700, 2013. [PDF]

Li, Z., Gilbert, J.A., Zhang, Y., Qui,Q., Ramanujan, V.K., Shavlakadze, T., Eash, J.K., Scaramozza, A., Goddeeris, M.M., Kirsch, D.G., Campbell, K.P., Brack, A.S., Glass, D.J. An HMGA2-IGF2BP2 Axis Regulates Myoblast Proliferation and Myogenesis. Dev Cell. 23: 1-13, 2012. [PDF]

Beedle, A., Turner, A., Saito, Y., Lueck, J.D., Nenaber, T. and Campbell, K.P. Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy. J Clin Invest. 122(9): 3330-3342, 2012. [PDF]

Rojek, J.M., Moraz, M.-L., Pythoud, C., Rothernberger, S., Gisou Van der Goot, F., Campbell, K.P., and Kunz, S. Binding of Lassa virus perturbs extracellular matrix-induced transduction via dystroglycan. Cell Microbiol. 14: 1122-1134, 2012. [PDF]

Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., Beltran Valero de Bernabe, D., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Loder, A.S., Dobyns, W.B., Winder, T.L., Strahl, S., Mathews, K.D., Nelson, S.F., Moore, S.A., and Campbell, K.P. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat. Genet.. 44: 575-80, 2012. [PDF]

Inamori, K., Yoshida-Moriguchi, T., and Campbell, K.P. New insights into laminin-binding gylcoslyation on alpha-dystroglycan. Life Science Shinchaku Ronbun Review 30: 1775-1777, 2012. [PDF]

Kobayashi, Y.M., Rader, E.P., Crawford, R.W. and Campbell, K.P. Endpoint Measures in the mdx Mouse Relevant for Muscular Dystrophy Pre-clinical Studies. Neuromuscul. Disord. 22: 34-42, 2012. [PDF]

Inamori, K., Yoshida-Moriguchi, T., Hara, Y., Anderson, M.E., Yu, L. and Campbell, K.P. Dystroglycan Function Requires Xylosyl- and Glucuronyltransferase Activities of LARGE. Science. 335: 93-96, 2012. [PDF]

Han, R., Rader, E.P., Levy, J.R., Bansal, D. and Campbell, K.P. Dystrophin Deficiency Exacerbates Skeletal Muscle Pathology in Dysferlin-null Mice. Skelet. Muscle. 1: 35, 2011. [PDF]

Di Blasi, C., Bellafiore, E., Salih, M.A.M., Manzini, M.C., Moore, S.A., Seidahmed, M.Z., Mukhtar, M.M., Karrar, Z.A., Walsh, C.A., Campbell, K.P., Mantegazza, R., Morandi, L. and Mora, M. Variable Disease Severity in Saudi Arabian and Sudanese Families with c.3924+2 T>C Mutation of LAMA2. BMC Res. Notes. 4: 534, 2011. [PDF]

Lancioni, A., Luisa Rotundo, I., Kobayashi, Y.M., D'Orsi, L., Aurino, S., Nigro, G., Piluso, G., Acampora, D., Cacciottolo, M., Campbell, K.P., Nigro, V. Combined Deficiency of Alpha and Epsilon Sarcoglycan Disrupts the Cardiac Dystrophin Complex. Hum. Mol. Genet. 20: 4644-54, 2011. [PDF]

Hara, Y., Kanagawa, M., Kunz, S., Yoshida-Moriguchi, T., Satz, J.S., Kobayashi, Y.M., Zhu, Z., Burden, S.J., Oldstone, M.B.A., Campbell, K.P. LARGE-dependent Modification of Dystroglycan at Thr-317-319 is Required for Laminin Binding and Arenavirus Infection. Proc. Natl. Acad. Sci. USA. 108: 17426-31, 2011. [PDF]

Alnawaiseh, M., Albanna, W., Chen, C.-C., Campbell, K.P., Hescheler, J., Luke, M., Scheider, T. Two Separate Ni2+-sensitive Voltage-gated Ca2+ Channels Modulate Transretinal Signaling in the Isolated Murine Retina. Acta Ophthalmol. 89: e579-90, 2011. [PDF]

Lei, D., Gao, X., Perez, P., Ohlemiller, K.K., Chen, C.-C., Campbell, K.P., Hood, A.Y., Bao, J. Anti-Epileptic Drugs Delay Age-Related Loss of Spiral Ganglion Neurons via T-type Calcium Channel. Hear. Res. 278: 106-12, 2011. [PDF]

Noell, S., Wolburg-Buchholz, K., Mack, A.F., Beedle, A.M., Satz, J.S., Campbell, K.P., Wolburg, H., Fallier-Becker, P. Evidence for a Role of Dystroglycan Regulating the Membrane Architecture of Astroglial Endfeet. Eur.J. Neurosci. 33: 2179-86, 2011. [PDF]

Stalnaker, S.H., Aoki, K., Lim, J.M., Porterfield, M., Lui, M., Satz, J.S., Buskirk, S., Campbell, K.P., Hu, H., Live, D., Tiemeyer, M., Wells, L. Glycomic Analysis of Mouse Models of Congenital Muscular Dystrophy. J. Biol. Chem. 286: 21180-90, 2011. [PDF]

Clark, N.F., Maugenre, S., Vandebrouck, A., Urtizberea, J.A., Willer, T., Peat, R., Gray, F., Bouchet, C., Manya, H., Vuillaumier-Barrot., S., Endo, T., Chouery, E., Campbell, K.P., Megabane, A., Guicheney, P. Congenital Muscular Dystrophy Type 1D (MDC1D) Due to a Large Intragenic Insertion/Deletion Involving Intron 10 of the LARGE Gene. Eur. J. Human Genet. 19: 452-57, 2011. [PDF]

Hara, Y., Balci, B., Kanagawa, M., Beltran-Valero de Bernabe, D., Gundesli, H., Yoshida-Moriguchi, T., Willer, T., Satz, J.S., Burden, S.J., Oldstone, M.B.A., Accardi, A., Talim, B., Muntoni, F., Topaloglum, H., Dincer, P., Campbell, K.P. A Dystroglycan Mutation Associated with Limb-Girdle Muscular Dystrophy. N. Eng. J. Med. 364: 939-46, 2011. [PDF]

Sullivan, B.M., Emonet, S., Welch, M.J.., Lee, A.M., Campbell, K.P., de la Torre, J.C., Oldstone, M.B.A. Point Mutation in the Glycoprotein of Lymphocyctic Chroriomeningitis Virus is Necessary for Receptor Binding, Dendritic Cell Infection, and Long-term Persistence. Proc. Natl. Acad. Sci. U.S.A. 108: 2969-74, 2011. [PDF]

Lueck, J., Rossi, A.E., Thornton, C.A., Campbell, K.P., Dirksen, R.T. Response to the letter: "On the localization of CIC-1 in skeletal muscle fibers." J. Gen. Physiol. 137: 331-33, 2011. [PDF]

Wu, J., Ruas, J.L., Estall, J.L., Rasbach, K.A., Choi, J.H., Ye, L., Bostrom, P., Tyra, H.M., Crawford, R.W., Campbell, K.P. The Unfolded Protein Response Mediates Adaptation to Exercise in Skeletal Muscle through a PGC-1α/ATF6α Complex. Cell. Metab. 13: 160-69, 2011. [PDF]

Mathews, K.D., Stephan, C.M., Laubenthal, K., Winder, T.L., Michele, D.E., Moore, S.A., Campbell, K.P. Myoglobinuria and Muscle Pain are Common in Patients with Limb-Girdle Muscular Dystrophy 2I. Neurol. 76: 194-95, 2011. [PDF]


Campbell Laboratory; 285 Newton Road, 4283 Carver Biomedical Research Building, Iowa City, IA 52242